Board Meeting3 Aug 2026, 03:51 pm
Kwality Pharmaceuticals Board Meeting on Aug 10 to Approve Financial Results
AI Summary
Kwality Pharmaceuticals Ltd has announced that its Board of Directors will convene on August 10, 2026, to consider and approve the standalone and consolidated unaudited financial results for the quarter ending June 30, 2026. The company also confirmed that the trading window for designated persons will remain closed until 48 hours after the declaration of these financial results. The meeting is scheduled to take place at the company's registered office in Amritsar.
Key Highlights
- Board meeting scheduled for August 10, 2026.
- To approve standalone and consolidated financial results.
- Financial results are for the quarter ended June 30, 2026.
- Trading window closure extended until results declaration.
- Meeting to be held at the registered office in Amritsar.
Price Impact
More from KPL
Insider Trading28 Sept, 12:41 pm
Kwality Pharmaceuticals Closes Trading Window for Insider Trading
Quarterly Result10 Aug, 12:28 pm
Kwality Pharma Declares Q1 FY27 Unaudited Financial Results
Quarterly Result10 Aug, 12:11 pm
Kwality Pharma Q1FY27: consolidated PAT surges 115% YoY to ₹25.6 Cr, margins expand, guidance raised